QBioMed has the global exclusive rights to develop and market a novel chemotherapeutic drug to treat liver cancer.
Investigating the role of obesity in arthritis
Osteoarthritis, or OA, is the most common form of disability in the U.S.
Trio of new grants brings $2.7 million to OMRF labs
Awards “a testament to the quality of research in Oklahoma”
Biotech company acquires OMRF brain cancer drug
Agreement will expand clinical trials of glioblastoma drug
Love and other drugs
Brain scans of people who are in love look similar to scans of drug addicts.
Research brings new view of difficult urinary disorder
Contrast MRI may lead to better diagnosis for bladder pain syndrome